Currently predicting for Tue, 28 May 2024

Trading levels for CRDF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.57 8.08 %
R2 3.48 5.53 %
R1 3.43 3.96 %
Current price: 3.30
Support S1 3.26 -1.13 %
S2 3.21 -2.71 %
S3 3.13 -5.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.89 17.88 %
R2 3.65 10.61 %
R1 3.49 5.76 %
Current price 3.30
Support S1 3.20 -3.03%
S2 2.91 -11.82%
S3 0 .

CRDF Predictions History

1 year ago
JS predicted that CRDF for 2022-06-27 is going $2.14 (-3.60%)

1 year ago
connorjmeier predicted that CRDF for 2022-06-27 is going $2.21 (-2.64%)

Rank:

1 year ago
Sagar Patil predicted that CRDF for 2022-06-27 is going $2.20 (-3.08%)

Rank:

1 year ago
JS predicted that CRDF for 2022-06-13 is going $2.01 (4.69%)

1 year ago
titrolospe predicted that CRDF for 2022-06-13 is going $2.80 (30.84%)

Rank:

2 years ago
JS predicted that CRDF for 2022-04-19 is going $1.57 (-4.27%)

3 years ago
JS predicted that CRDF for 2021-02-25 is going $10.70 (9.74%)

3 years ago
Kevin Ripper predicted that CRDF for 2021-02-25 is going $11.28 (15.69%)

Rank:

3 years ago
sander7100 yo bro predicted that CRDF for 2020-09-28 is going $11.66 (-4.27%)

3 years ago
JS predicted that CRDF for 2020-09-28 is going $11.68 (-4.11%)

Click to get the best stock tips daily for free!

About Cardiff Oncology Inc.

Cardiff Oncology. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac... CRDF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT